Carole D. Mitnick

9.2k total citations
113 papers, 3.7k citations indexed

About

Carole D. Mitnick is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Carole D. Mitnick has authored 113 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Infectious Diseases, 73 papers in Epidemiology and 26 papers in Surgery. Recurrent topics in Carole D. Mitnick's work include Tuberculosis Research and Epidemiology (86 papers), Pneumonia and Respiratory Infections (34 papers) and Pneumocystis jirovecii pneumonia detection and treatment (32 papers). Carole D. Mitnick is often cited by papers focused on Tuberculosis Research and Epidemiology (86 papers), Pneumonia and Respiratory Infections (34 papers) and Pneumocystis jirovecii pneumonia detection and treatment (32 papers). Carole D. Mitnick collaborates with scholars based in United States, Peru and South Africa. Carole D. Mitnick's co-authors include Jaime Bayona, Mercedes C. Becerra, Jennifer Furin, Megan Murray, Leonid Lecca, Sonya Shin, Molly F. Franke, Karen R. Jacobson, Guy B. Marks and Dylan B. Tierney and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Carole D. Mitnick

112 papers receiving 3.5k citations

Peers

Carole D. Mitnick
Dennis Falzon Switzerland
Kogieleum Naidoo South Africa
Charles D. Wells United States
Afrânio Lineu Kritski Brazil
Matthew Bates United Kingdom
Nathan Kapata Zambia
Nesri Padayatchi South Africa
Bachti Alisjahbana Indonesia
Jeremiah Chakaya Kenya
Haileyesus Getahun Switzerland
Dennis Falzon Switzerland
Carole D. Mitnick
Citations per year, relative to Carole D. Mitnick Carole D. Mitnick (= 1×) peers Dennis Falzon

Countries citing papers authored by Carole D. Mitnick

Since Specialization
Citations

This map shows the geographic impact of Carole D. Mitnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole D. Mitnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole D. Mitnick more than expected).

Fields of papers citing papers by Carole D. Mitnick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole D. Mitnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole D. Mitnick. The network helps show where Carole D. Mitnick may publish in the future.

Co-authorship network of co-authors of Carole D. Mitnick

This figure shows the co-authorship network connecting the top 25 collaborators of Carole D. Mitnick. A scholar is included among the top collaborators of Carole D. Mitnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole D. Mitnick. Carole D. Mitnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Platt, Georgina, Charles A. Peloquin, Julia Coit, et al.. (2025). Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial. The Journal of Infectious Diseases. 232(2). e258–e265.
2.
Phillips, Patrick, Charles A. Peloquin, Andreas H. Diacon, et al.. (2025). Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 211(7). 1277–1287. 1 indexed citations
3.
Almeida, Carlos Podalírio Borges de, et al.. (2024). “You find yourself in a very humiliating situation”: experiences of people living with post-tuberculosis lung disease in Brazil. Frontiers in Public Health. 12. 1431881–1431881. 1 indexed citations
4.
Franke, Molly F., Letizia Trevisi, Askar Yedilbayev, et al.. (2024). Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan. Clinical Infectious Diseases. 79(4). 1046–1053. 3 indexed citations
5.
Law, Stephanie, Marco Tovar, Molly F. Franke, et al.. (2023). Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru. BMC Infectious Diseases. 23(1). 62–62. 1 indexed citations
6.
Patterson, Rolvix H., Alexis N. Bowder, Blake C. Alkire, et al.. (2022). Impact of out-of-pocket expenses for surgical care on households in rural Haiti: a mixed-methods study. BMJ Open. 12(5). e061731–e061731. 6 indexed citations
7.
Rahman, Rifat, et al.. (2022). Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different. PLoS ONE. 17(7). e0271102–e0271102. 5 indexed citations
8.
Jung, David H., et al.. (2022). Prevention and management of hearing loss in patients receiving ototoxic medications. Bulletin of the World Health Organization. 100(12). 789–796A. 7 indexed citations
9.
Contreras, Carmen, Leonid Lecca, Jerome T. Galea, et al.. (2022). Using digital chatbots to close gaps in healthcare access during the COVID-19 pandemic. Public Health Action. 12(4). 180–185. 15 indexed citations
10.
Rodriguez, Carly A., Karla Therese L. Sy, Carole D. Mitnick, & Molly F. Franke. (2020). Time-Dependent Confounding in Tuberculosis Treatment Outcome Analyses: A Review of a Source of Bias. American Journal of Respiratory and Critical Care Medicine. 202(9). 1311–1314. 1 indexed citations
11.
Phillips, Patrick, Carole D. Mitnick, James D. Neaton, et al.. (2019). Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape. PLoS Medicine. 16(3). e1002767–e1002767. 15 indexed citations
12.
Law, Stephanie, Amrita Daftary, Carole D. Mitnick, Keertan Dheda, & Dick Menzies. (2019). Disrupting a cycle of mistrust: A constructivist grounded theory study on patient-provider trust in TB care. Social Science & Medicine. 240. 112578–112578. 15 indexed citations
13.
Rodriguez, Carly A., Meredith B. Brooks, Lorenzo Guglielmetti, et al.. (2019). Barriers and facilitators to early access of bedaquiline and delamanid for MDR-TB: a mixed-methods study. Public Health Action. 9(1). 32–41. 7 indexed citations
14.
Velásquez, Gustavo E., Meredith B. Brooks, Julia Coit, et al.. (2018). Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 198(5). 657–666. 74 indexed citations
15.
Lange, Christoph, Frank van Leth, Carole D. Mitnick, Keertan Dheda, & Gunar Günther. (2018). Time to revise WHO-recommended definitions of MDR-TB treatment outcomes. The Lancet Respiratory Medicine. 6(4). 246–248. 9 indexed citations
16.
17.
Franke, Molly F., Mercedes C. Becerra, Dylan B. Tierney, et al.. (2015). Counting Pyrazinamide in Regimens for Multidrug-Resistant Tuberculosis. Annals of the American Thoracic Society. 12(5). 674–679. 18 indexed citations
18.
Becerra, Mercedes C., Molly F. Franke, Sasha C. Appleton, et al.. (2012). Tuberculosis in Children Exposed at Home to Multidrug-resistant Tuberculosis. The Pediatric Infectious Disease Journal. 32(2). 115–119. 24 indexed citations
19.
Podewils, Laura Jean, et al.. (2012). Concordance of programmatic and laboratory-based multidrug-resistant tuberculosis treatment outcomes in Peru. The International Journal of Tuberculosis and Lung Disease. 16(3). 364–369. 3 indexed citations
20.
Espinal, Marcos, Pedro Suarez, Tim Cullinan, et al.. (2002). TB Control and Access to Second-Line Drugs: Better Model Needed. (Round Table Discussion). Bulletin of the World Health Organization. 80(6). 495–500. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis Falzon Breakdown of academic impact, for papers by Kogieleum Naidoo Breakdown of academic impact, for papers by Charles D. Wells Breakdown of academic impact, for papers by Afrânio Lineu Kritski Breakdown of academic impact, for papers by Matthew Bates Breakdown of academic impact, for papers by Nathan Kapata Breakdown of academic impact, for papers by Nesri Padayatchi Breakdown of academic impact, for papers by Bachti Alisjahbana Breakdown of academic impact, for papers by Jeremiah Chakaya Breakdown of academic impact, for papers by Haileyesus Getahun
Rankless by CCL
2026